XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Tables)
3 Months Ended
Apr. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Classification of Stock-based Compensation

The following table presents the classification of stock-based compensation for the periods indicated:

 

 

 

Three Months Ended April 30,

 

 

 

 

2021

 

 

2020

 

 

 

 

(in thousands)

Stock-based compensation:

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

323

 

 

$

297

 

 

Research and development

 

 

11,194

 

 

 

9,896

 

 

Selling, general and administrative

 

 

7,325

 

 

 

5,843

 

 

Total stock-based compensation

 

$

18,842

 

 

$

16,036

 

 

Weighted-Average Assumptions Used to Estimate Fair Value

The following table sets forth the weighted-average assumptions used to estimate the fair value of stock options and employee stock purchase plan awards for the periods indicated:

 

 

 

Three Months Ended April 30,

 

 

 

 

2021

 

 

2020

 

 

Stock Options:

 

 

 

 

 

 

 

 

 

Volatility

 

 

51

%

 

 

50

%

 

Risk-free interest rate

 

 

0.99

%

 

 

0.74

%

 

Expected term (years)

 

5.3

 

 

5.89

 

 

Dividend yield

 

 

0

%

 

 

0

%

 

Employee stock purchase plan awards:

 

 

 

 

 

 

 

 

 

Volatility

 

 

61

%

 

 

61

%

 

Risk-free interest rate

 

 

0.06

%

 

 

0.29

%

 

Expected term (years)

 

0.5

 

 

0.5

 

 

Dividend yield

 

 

0

%

 

 

0

%

 

 

Stock Option Activities

The following table summarizes stock option activities for the period indicated:

 

 

 

 

Option Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Intrinsic

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Value Of

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Average

 

 

Options

 

 

Contractual

 

 

Intrinsic

 

 

 

 

 

 

 

Average

 

 

Grant-date

 

 

Exercised

 

 

Term

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Fair Value

 

 

(in thousands)

 

 

(in years)

 

 

(in thousands)

 

Outstanding at January 31, 2021

 

 

719,143

 

 

$

38.33

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

13,100

 

 

 

111.51

 

 

$

51.10

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(77,403

)

 

 

27.77

 

 

 

 

 

 

$

6,363

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(3,131

)

 

 

55.43

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at April 30, 2021

 

 

651,709

 

 

 

40.98

 

 

 

 

 

 

 

 

 

 

4.46

 

 

$

37,040

 

Exercisable at April 30, 2021

 

 

531,761

 

 

$

36.80

 

 

 

 

 

 

 

 

 

 

 

3.56

 

 

$

32,298

 

Restricted Stock Units Activities

The following table summarizes the restricted stock units activities for the period indicated:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at January 31, 2021

 

 

2,871,801

 

 

$

51.73

 

Granted

 

 

325,866

 

 

 

107.62

 

Vested

 

 

(565,717

)

 

 

51.63

 

Forfeited

 

 

(11,974

)

 

 

60.25

 

Unvested at April 30, 2021

 

 

2,619,976

 

 

$

58.67